BioCentury
ARTICLE | Company News

Actavis, TPG Capital deal

May 18, 2015 7:00 AM UTC

Actavis completed the divestiture of its Aptalis Pharmaceutical Technologies subsidiary to private investment firm TPG for an undisclosed sum. Aptalis said that its new name is Adare Pharmaceuticals (...